Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Understanding perceptions of genital herpes disclosure through analysis of an online video contest.

Catallozzi M, Ebel SC, Chávez NR, Shearer LS, Mindel A, Rosenthal SL.

Sex Transm Infect. 2013 Dec;89(8):650-2. doi: 10.1136/sextrans-2013-051027. Epub 2013 May 23.

PMID:
23702459
2.

Does perception of relationship type impact sexual health risk?

Catallozzi M, Bell DL, Short MB, Marcell AV, Ebel SC, Rosenthal SL.

Sex Transm Dis. 2013 Jun;40(6):473-5. doi: 10.1097/OLQ.0b013e318287bf44.

PMID:
23680904
3.

Regulation of IDO activity by oxygen supply: inhibitory effects on antimicrobial and immunoregulatory functions.

Schmidt SK, Ebel S, Keil E, Woite C, Ernst JF, Benzin AE, Rupp J, Däubener W.

PLoS One. 2013 May 13;8(5):e63301. doi: 10.1371/journal.pone.0063301. Print 2013.

4.

Do mentors know who they are mentoring?

Rosenthal SL, Ebel SC, Omondi EA, Hum RS.

J Pediatr. 2012 Nov;161(5):773-4. doi: 10.1016/j.jpeds.2012.07.059. No abstract available.

PMID:
23095689
5.
6.

Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.

Reimers N, Zafrakas K, Assmann V, Egen C, Riethdorf L, Riethdorf S, Berger J, Ebel S, Jänicke F, Sauter G, Pantel K.

Clin Cancer Res. 2004 May 15;10(10):3422-8.

7.

Comparative evaluation of urokinase-type plasminogen activator receptor expression in primary breast carcinomas and on metastatic tumor cells.

Hemsen A, Riethdorf L, Brünner N, Berger J, Ebel S, Thomssen C, Jänicke F, Pantel K.

Int J Cancer. 2003 Dec 20;107(6):903-9.

8.

Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.

Thurm H, Ebel S, Kentenich C, Hemsen A, Riethdorf S, Coith C, Wallwiener D, Braun S, Oberhoff C, Jänicke F, Pantel K.

Clin Cancer Res. 2003 Jul;9(7):2598-604.

9.

Safety of FFR-based treatment strategies: the Munich experience.

Rieber J, Jung P, Schiele TM, Koenig A, Erhard I, Segmiller T, Ebel S, Theisen K, Siebert U, Klauss V.

Z Kardiol. 2002;91 Suppl 3:115-9.

PMID:
12641025
10.

Two-year follow-up study of elderly residents in S. Paulo, Brazil: methodology and preliminary results.

Ramos LR, Toniolo J, Cendoroglo MS, Garcia JT, Najas MS, Perracini M, Paola CR, Santos FC, Bilton T, Ebel SJ, Macedo MB, Almada CM, Nasri F, Miranda RD, Gonçalves M, Santos AL, Fraietta R, Vivacqua I, Alves ML, Tudisco ES.

Rev Saude Publica. 1998 Oct;32(5):397-407.

PMID:
10030055
11.

Lithium/carbon monofluoride (Li/CFx): a new pacemaker battery.

Greatbatch W, Holmes CF, Takeuchi ES, Ebel SJ.

Pacing Clin Electrophysiol. 1996 Nov;19(11 Pt 2):1836-40.

PMID:
8945052
12.

[Changes in the approbation regulation for pharmacists?].

Ebel S.

Med Monatsschr Pharm. 1995 Sep;18(9):272-3; discussion 273-4. German. No abstract available.

PMID:
7476664
13.

Using linkers to investigate the spatial separation of the conserved nucleotides A9 and G12 in the hammerhead ribozyme.

Hendry P, Moghaddam MJ, McCall MJ, Jennings PA, Ebel S, Brown T.

Biochim Biophys Acta. 1994 Oct 18;1219(2):405-12.

PMID:
7522573
14.

Crystal and molecular structure of r(CGCGAAUUAGCG): an RNA duplex containing two G(anti).A(anti) base pairs.

Leonard GA, McAuley-Hecht KE, Ebel S, Lough DM, Brown T, Hunter WN.

Structure. 1994 Jun 15;2(6):483-94.

PMID:
7922026
15.
16.

Properties of multiple G.A mismatches in stable oligonucleotide duplexes.

Lane A, Ebel Sy, Brown T.

Eur J Biochem. 1994 Mar 15;220(3):717-27.

17.
18.

Branched poly-labelled oligonucleotides: enhanced specificity of fork-shaped biotinylated oligoribonucleotides for antisense affinity selection.

Teigelkamp S, Ebel S, Will DW, Brown T, Beggs JD.

Nucleic Acids Res. 1993 Sep 25;21(19):4651-2. No abstract available.

19.

The role of the physical therapist in hospice care.

Ebel S, Langer K.

Am J Hosp Palliat Care. 1993 Sep-Oct;10(5):32-5.

PMID:
8398475
20.

NMR assignments and solution conformation of the DNA.RNA hybrid duplex d(GTGAACTT).r(AAGUUCAC).

Lane AN, Ebel S, Brown T.

Eur J Biochem. 1993 Jul 15;215(2):297-306.

21.
22.

Solution conformation of a deoxynucleotide containing tandem G.A mismatched base pairs and 3'-overhanging ends in d(GTGAACTT)2.

Lane A, Martin SR, Ebel S, Brown T.

Biochemistry. 1993 Apr 13;32(14):3829. No abstract available.

PMID:
8466920
23.

Very stable mismatch duplexes: structural and thermodynamic studies on tandem G.A mismatches in DNA.

Ebel S, Lane AN, Brown T.

Biochemistry. 1992 Dec 8;31(48):12083-6.

PMID:
1457405
24.
25.

Barnase has subsites that give rise to large rate enhancements.

Day AG, Parsonage D, Ebel S, Brown T, Fersht AR.

Biochemistry. 1992 Jul 21;31(28):6390-5.

PMID:
1633151
26.

[Hand disinfection as the central factor in prevention of puerperal mastitis. Clinical study and results of a survey].

Peters F, Flick-Filliés D, Ebel S.

Geburtshilfe Frauenheilkd. 1992 Feb;52(2):117-20. German.

PMID:
1568632
27.

Pore-forming peptide of pathogenic Entamoeba histolytica.

Leippe M, Ebel S, Schoenberger OL, Horstmann RD, Müller-Eberhard HJ.

Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7659-63.

28.

[Analytical methods for stability testing of metronidazole infusion solutions].

Ebel S, Ledermann M, Mümmler B.

Arch Pharm (Weinheim). 1990 Apr;323(4):195-200. German.

PMID:
2360862
29.

[Determination of the release of drugs from transdermal therapeutic systems. Presentation of a new release system].

Chen LS, Ebel S, Hoffmann U, Osterwald HP.

Arzneimittelforschung. 1989 Nov;39(11A):1494-7. German.

PMID:
2624596
30.

The llama industry in the United States.

Ebel S.

Vet Clin North Am Food Anim Pract. 1989 Mar;5(1):1-20.

PMID:
2784344
31.

Analytical oxidation of reserpine.

Ebel S, Mück W, Placke FJ.

J Pharm Biomed Anal. 1989;7(6):709-13.

PMID:
2490774
32.

[Screening and detection of tetrazepam and its major metabolites].

Schütz H, Ebel S, Fitz H.

Arzneimittelforschung. 1985;35(7):1015-24. German.

PMID:
2864931
33.

[Evaluation of anthraquinone drugs. I. Hydrolysis of the glycosides in TLC-plates (author's transl)].

Ebel S, Kaal M.

Planta Med. 1980 Nov;40(3):271-7. German. No abstract available.

PMID:
7443843
34.

[Reactions of thin-layer plates].

Schütz H, Ebel S.

Pharm Unserer Zeit. 1980 Sep;9(5):139-51. German. No abstract available.

PMID:
7465600
35.

[Determination of salicylamide in blood using direct injection HPLC].

Ebel S, Liedtke R, Missler B.

Arch Pharm (Weinheim). 1980 Aug;313(8):674-9. German. No abstract available.

PMID:
7416925
36.

[Determination of morphine and its degradation products in drugs by TLC (author's transl)].

Ebel S, Rost D.

Arch Pharm (Weinheim). 1980 Apr;313(4):337-43. German. No abstract available.

PMID:
7396666
37.

[Determination of paracetamol in blood samples by HPLC (author's transl)].

Ebel S, Liedtke R, Missler B.

Arch Pharm (Weinheim). 1980 Apr;313(4):324-9. German. No abstract available.

PMID:
7396665
38.

[Quantitative determination of nitrofurantoin in body fluids by direct injection HPLC].

Ebel S, Liedtke R, Missler B.

Arch Pharm (Weinheim). 1980 Jan;313(1):95-6. German. No abstract available.

PMID:
7369831
39.

[Multiple-dose pharmacokinetics of paracetamol and salicylamide in man after combined rectal application (author's transl)].

Liedtke R, Ebel S, Missler B, Haase W, Stein L.

Arzneimittelforschung. 1980;30(8):1295-8. German.

PMID:
7192145
40.

Single-dose pharmacokinetics of macrocrystalline nitrofurantoin formulations.

Liedtke RK, Ebel S, Missler B, Haase W, Stein L.

Arzneimittelforschung. 1980;30(5):833-6.

PMID:
7190430
41.

[Bioavailability of nitrofurantoin; II: Quantitative determination nitrofurantoin in blood serum (author's transl)].

Ebel S, Liedtke R, Missler B, Richter M, Surmann P.

Arch Pharm (Weinheim). 1979 Aug;312(8):697-703. German. No abstract available.

PMID:
496585
42.

[Quantitative determination of nitrofurantoin in urine (author's transl)].

Ebel S, Liedtke R, Missler B, Richter M, Surmann P.

Arch Pharm (Weinheim). 1979 Aug;312(8):689-96. German. No abstract available.

PMID:
496584
43.

[Biotransformation of benzodiazepine derivatives].

Ebel S, Schütz H.

Pharm Unserer Zeit. 1979 May;8(3):87-93. German. No abstract available.

PMID:
38464
44.

[Determination of ephedrine in drugs using quantitative thin-layer chromatography].

Ebel S, Rost D.

Arch Pharm (Weinheim). 1979 Feb;312(2):100-7. German. No abstract available.

PMID:
435021
45.
46.

[Biotransformation of nefopam (Ajan), I: isolation and identification of the main metabolite and some other metabolites (author's transl)].

Ebel S, Schütz H.

Arch Pharm (Weinheim). 1978 Jun;311(6):547-52. German. No abstract available.

PMID:
678062
48.
49.

[Analytical data of nefopam (Ajan), a new analgetic with an agency similar to that of morphine (author's transl)].

Ebel S, Schütz H.

Arch Toxicol. 1977 Nov 21;38(4):239-50. German. No abstract available.

PMID:
579970
50.

[Analysis and biotransformation of mazindol (Teronac) a new anti-obesity drug].

Ebel S, Schütz H.

Arch Kriminol. 1977 Sep-Oct;160(3-4):78-86. German. No abstract available.

PMID:
931504

Supplemental Content

Support Center